| 发明名称 |
Use of Melanocortins to Treat Insulin Sensitivity |
| 摘要 |
The present invention relates to peptide ligands of the melanocortin receptors, in particular the melancortin-4 receptor, and as such, are useful in the treatment of disorders responsive to the activation of this receptor, such as insulin resistance. |
| 申请公布号 |
US2016354429(A1) |
申请公布日期 |
2016.12.08 |
| 申请号 |
US201615242866 |
申请日期 |
2016.08.22 |
| 申请人 |
Ipsen Pharma S.A.S. |
发明人 |
HALEM Heather A.;CULLER Michael DeWitt;BUTLER Andrew A. |
| 分类号 |
A61K38/12 |
主分类号 |
A61K38/12 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating insulin resistance in a subject in need thereof, comprising peripheral administration of an effective amount of a melanocortin receptor 4 agonist to treat said insulin resistance in said subject in need thereof. |
| 地址 |
Boulogne-Billancourt FR |
